Berkeley Capital Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.5M Buy
8,061
+42
+0.5% +$7.8K 0.38% 54
2025
Q1
$1.68M Buy
8,019
+166
+2% +$34.8K 0.46% 45
2024
Q4
$1.4M Sell
7,853
-124
-2% -$22K 0.39% 49
2024
Q3
$1.58M Buy
7,977
+773
+11% +$153K 0.45% 45
2024
Q2
$1.24M Sell
7,204
-18
-0.2% -$3.09K 0.37% 53
2024
Q1
$1.32M Sell
7,222
-193
-3% -$35.1K 0.4% 48
2023
Q4
$1.15M Sell
7,415
-136
-2% -$21.1K 0.38% 47
2023
Q3
$1.13M Buy
7,551
+57
+0.8% +$8.5K 0.41% 47
2023
Q2
$1.01M Buy
7,494
+30
+0.4% +$4.04K 0.36% 58
2023
Q1
$1.19M Buy
7,464
+278
+4% +$44.3K 0.44% 46
2022
Q4
$1.16M Sell
7,186
-196
-3% -$31.7K 0.45% 48
2022
Q3
$991K Buy
7,382
+24
+0.3% +$3.22K 0.43% 43
2022
Q2
$1.13M Buy
7,358
+25
+0.3% +$3.83K 0.46% 38
2022
Q1
$1.19M Buy
7,333
+931
+15% +$151K 0.47% 32
2021
Q4
$867K Sell
6,402
-186
-3% -$25.2K 0.36% 42
2021
Q3
$711K Sell
6,588
-102
-2% -$11K 0.33% 48
2021
Q2
$754K Buy
6,690
+52
+0.8% +$5.86K 0.34% 43
2021
Q1
$718K Buy
6,638
+289
+5% +$31.3K 0.35% 47
2020
Q4
$680K Buy
6,349
+12
+0.2% +$1.29K 0.35% 44
2020
Q3
$555K Buy
6,337
+238
+4% +$20.8K 0.34% 46
2020
Q2
$599K Buy
6,099
+195
+3% +$19.2K 0.37% 46
2020
Q1
$450K Buy
5,904
+324
+6% +$24.7K 0.31% 69
2019
Q4
$494K Sell
5,580
-1,505
-21% -$133K 0.25% 80
2019
Q3
$536K Sell
7,085
-1,095
-13% -$82.8K 0.28% 74
2019
Q2
$595K Buy
8,180
+2,423
+42% +$176K 0.28% 69
2019
Q1
$464K Buy
5,757
+1,056
+22% +$85.1K 0.23% 85
2018
Q4
$433K Buy
+4,701
New +$433K 0.24% 80